IMMUNIC, INC. — Director's Dealing 2015

Sep 11, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VITAL THERAPIES INC (VTL)
CIK: 0001280776
Period of Report: 2015-09-09

Reporting Person: BIENAIME JEAN JACQUES (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-09-09	Common Stock	P	4000	$3.07	Acquired	29119	Direct
2015-09-09	Common Stock	P	2000	$3.10	Acquired	31119	Direct
2015-09-09	Common Stock	P	2000	$3.16	Acquired	33119	Direct
2015-09-10	Common Stock	P	6000	$3.0489	Acquired	39119	Direct

Footnotes

F1: Represents the weighted average share price of an aggregate total of 6,000 shares purchased in the price range of $3.04 to $3.0599 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.